Dr. Graham is Chief Health Officer at Truth Initiative where leads a cross-functional team that develops, evaluates, and disseminates digital programs for tobacco cessation. She is also Professor of Medicine (adjunct) at the Mayo Clinic College of Medicine and Science and Professor of Oncology (adjunct) at Georgetown University Medical Center. For the past 25 years,… Read more »
Trained as a physician and a lawyer, Dr. Yagi is interested in a broad array of health policy topics at the intersection of medicine and law. His experience in FDA’s Office of Policy and Planning has led to a passion about how FDA can regulate the wide variety of products under its purview, as well… Read more »
Dr. Meza’s research interests lie at the interface of epidemiology, biostatistics and biomathematics. He is an expert in lung cancer epidemiology and prevention and tobacco epidemiology and control. The goal of his research program is to characterize the impact of disease prevention and control interventions, informing stakeholders and policy makers as to the most effective… Read more »
Dr. Higgins is Director of UVM’s Vermont Center on Behavior and Health, and Principle Investigator with three NIH grants on the general topic of behavior and health. He is the Virginia H. Donaldson Endowed Professor of Translational Science in the Department of Psychological Science and serves as Vice Chair of Psychiatry. He has held many… Read more »
Martin is Tobacco Control Programme Lead for (OHID) The Office of Health Improvement and Disparities (previously Public Health England). He joined PHE in February after 7 years at Action on Smoking and Health. Martin has worked in Public Health since the mid 1980’s when he was involved in HIV prevention work. He is a fellow… Read more »
Professor Ron Borland (PhD) joined Deakin University School of Psychology in February 2024. He is transitioning from the University of Melbourne (2019-2024). Prior to that he was the Nigel Gray Distinguished Fellow in Cancer Prevention, at The Cancer Council Victoria, Australia where he worked for 33 years. He has published over 500 peer-reviewed papers mostly… Read more »
Andrea Villanti, Ph.D., M.P.H., is Deputy Director of the Rutgers Institute for Nicotine & Tobacco Studies and an associate professor in the Department of Health Behavior, Society, and Policy at the Rutgers School of Public Health. Previously, Dr. Villanti served on the faculty at the Johns Hopkins Bloomberg School of Public Health and the University… Read more »
Dr. Benjamin Toll is a licensed clinical psychologist, a Professor of Public Health Sciences and Psychiatry, the Vice Chair of Research for the Department of Public Health Sciences, and the Associate Director of Education and Training and Co-Director of the Lung Cancer Screening Program at MUSC Hollings Cancer Center, and Director of the MUSC Health… Read more »
Benjamin Apelberg, PhD is the Deputy Director for Regulatory Science in the Office of Science at FDA’s Center for Tobacco Products (CTP). In this role, he oversees scientific divisions responsible for managing the Office’s tobacco regulatory science research program, including the Population Assessment of Tobacco and Health (PATH) study and collaboration with CDC on the… Read more »
Alex comes from a background in customer service and logistics. Shortly after discovering the value of Tobacco Harm Reduction, he began volunteering his time for CASAA and was appointed to serve on CASAA’s Board of Directors in 2014, and later that same year was elected as CASAA’s Legislative Director. Alex stepped down from the Board… Read more »
Recent Comments